ArticlebioRxiv : the preprint server for biology2025

Ganaxolone, an approved therapy for CDKL5-Deficiency Disorder, is an inhibitor of PTP1B.

Imanol Zubiete-Franco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.